Target identified to improve immunotherapy against solid tumors: Transcription factor Blimp1
In cancer, a major obstacle to anti-tumor immunity and immunotherapy treatment is the infiltration of regulatory T cells, or T-reg cells, into a tumor. These immune cells generally turn down the immune response, and they ...